Below are your results for the search term: parkinson*
Search Again Back to previous page
- 1. Neuroprotection - Drugs, Markets and Companies
- 2. Transdermal Drug Delivery - Technologies, Markets, and Companies
- 3. World Neurodegeneratives Disease Markets, 2005-2009
- 4. The World's Top Ten Generic Companies
- 5. Tissue Engineering and Stem Cell Technology Report 2007
- 6. Cannabinoid Market Forecasts & Analysis to 2012
- 7. Cannabinoids: A potential blockbuster
- 8. Parkinson's Disease and Restless Legs Syndrome - Reformulations set to drive near-term growth
- 9. Parkinson's Disease - Review of Key Commercial Opportunities in the Symptomatic Treatment Market
- 10. The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
- 11. Teva Pharmaceutical Industries Market Forecasts & Analysis 2007-2012
- 12. Neurodegenerative Disease Drug Market Analysis and Forecasts 2007
- 13. PARKINSON DISEASE - Therapy Area Pipeline Report
- 14. Pipeline and Commercial Insight: Parkinson's Disease
- 15. Top Companies and Products in the RNA/DNA Therapy Products Market
- 16. The CNS Market Outlook
- 17. Commercial Insight: Parkinson's Disease - Increased Focus on Earlier Treatment and Managing Levodopa
- 18. The CNS Market Outlook to 2009
- 19. Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
- 20. Parkinson's Disease - Evidence of neuroprotection essential to progress treatment dynamics
- 21. Parkinson's Disease Market analysis and forecasts
- 22. CNS Market Overview - neurology, pain and psychiatry
- 23. Portable Inhaler Devices - Current Market and Life Cycle Opportunities
- 24. Top Generic Companies - Market Analysis and Forecasts
- 25. Vernalis plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
- 26. Titan Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
- 27. Diagnostics in Neurology - Predictive biomarkers expand drug revenues
- 28. Neuronal Nicotinic Receptors - October 2008
- 29. The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- 30. Neuronal Nicotinic Receptors - November 2008
- 31. Alnylam Pharmaceuticals Inc: Premium Company Profile
- 32. ACADIA Pharmaceuticals Inc.:Premium Company Profile
- 33. Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking
- 34. Companion Biomarkers in Drug Development
- 35. Therapeutic Monoclonal Antibodies Markets
- 36. World Neurodegenerative Diseases Market 2009-2024
- 37. World Neurodegenerative Diseases Market 2009-2024
- 38. What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- 39. Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
- 40. The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- 41. Biomarkers in Parkinson's Disease, 2010
- 42. Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015
- 43. Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
- 44. Regenerative Medicine Markets
1 - 44 results